BEIJING, May 4 (AFP) - The Chinese province worst-hit by HIV/AIDS is turning to traditional Chinese medicine because Western-style drugs proved to have too many side-effects and were too expensive, state media said Tuesday.
Central Henan province, which has at least 35,000 HIV/AIDS patients, will kick off a campaign next month to promote traditional medicines as a way to fight the disease, the China Daily said.
Efforts will be targeted mainly at the area's vast countryside, where most of Henan's HIV/AIDS carriers live.
The decision to use traditional medicine comes 10 months after China launched a program to provide free anti-retroviral drugs to thousands of AIDS-stricken farmers.
Health officials have since admitted the drugs are old, less effective versions, and around 20 percent of patients have stopped taking them because of severe side-effects.
Newer drugs are too expensive.
While patent expiration for major AIDS-treatment medicines has lowered the annual treatment costs for an AIDS patient in China to less than 20,000 yuan (2,415 dollars), it is still far beyond the means of the average Chinese.
The report said the new scheme would be launched at selected hospitals in the province. Teams will also be established to explore the potential of treating AIDS and HIV with traditional Chinese medicines.
Lin Ruichao, director of the Department of Traditional Chinese Medicine at the Beijing-based National Institute for the Control of Pharmaceuticals and Biological Products, was cited as saying there was "great potential" for traditional Chinese medicines to help treat HIV/AIDS.
So far though only one traditional medicine -- Tangcaopian -- has won a State Food and Drug Administration licence to be used to treat the disease.
Most of Henan's HIV/AIDS patients were infected through blood transfusions at illegal blood donor stations.
While the government says 35,000 people are infected in Henan, experts estimate at least one million farmers in the province alone contracted HIV/AIDS in the blood trade.
No-one has ever been held responsible.
040504
AF040511
©AFP 2004.. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission. http://www.afp.com/
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
©1990, 2004 - AEGiS. AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
